Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Open Study to Evaluate Safety and Efficacy of AS101 for the Treatment of Thrombocytopenia in Solid Tumor

NCT00926354 is registered in ClinicalTrials.gov with BioMAS Ltd as lead sponsor.

NCT NCT00926354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00926354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Open Study to Evaluate Safety and Efficacy of AS101 for the Treatment of Thrombocytopenia in Solid Tumor
Lead sponsor
BioMAS Ltd
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2009
Completion date
August 31, 2010
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy induced thrombocytopenia